PharmaLex Denmark A/S: Financial statements 2024
CVR: 18652439
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 26,015,255 and a net result of DKK 1,745,746. Equity in the 2024 report amounted to DKK 5,973,336. The solvency ratio was 47.6%. The company had 25 employees in the financial year.
- Gross Profit
- DKK 26,015,255
- Profit/Loss
- DKK 1,745,746
- Equity
- DKK 5,973,336
- Total Assets
- DKK 12,543,271
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 26M | 1.7M | 6M | 25 |
| 2022 | - | 30M | 5.8M | 6.6M | 29 |
| 2021 | - | 22.7M | 2.6M | 3.9M | 25 |
| 2020 | - | 21.5M | 4.3M | 6.2M | 23 |
| 2019 | - | 17M | 3.7M | 6M | 18 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 31, 2024, Eva Edil has joined the board of directors of PharmaLex Denmark A/S.
As of October 31, 2024, Laurent Maurice Robert Couston has left the board of directors of PharmaLex Denmark A/S.
As of October 1, 2024, Åsa Pihlblad has joined the board of directors of PharmaLex Denmark A/S.
As of October 1, 2024, Torben Thers Nørgaard has left the board of directors of PharmaLex Denmark A/S.
As of October 1, 2024, Åsa Pihlblad is registered as adm. dir. of PharmaLex Denmark A/S.
As of October 1, 2024, Torben Thers Nørgaard has stepped down as adm. dir. of PharmaLex Denmark A/S.
PharmaLex Denmark A/S has published its interim report for the period January 1, 2023 to September 30, 2023.
About PharmaLex Denmark A/S
PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.